WORKING WITH YOUR
MULTIPLE MYELOMA
CARE TEAM

Man talking with his doctor.

You are not alone in your treatment journey with multiple myeloma

It’s important to have open and honest conversations with your healthcare team. Use these questions to help prepare for your next conversation with your healthcare provider. You may want to also sign up to receive NINLARO resources and support emailed to you.

Woman talking with her doctor.

Questions you may wish to discuss

General questions

  • Can this treatment help my symptoms?
     
  • Why do I need this treatment? What benefits does it have?
     
  • How will we know this treatment is working? How long will it take for me to see an improvement?
     
  • I don’t have any symptoms. How do you know my multiple myeloma has returned?
     
  • Can you help me understand how this treatment works?
     
  • How will I know if my multiple myeloma is responding to treatment the way it should?
     
  • What does it mean if I achieve remission? How will I know if my multiple myeloma is controlled?
     
  • Can I make plans to travel?

Questions about lab work and tests

  • What typical tests and scans will I need?
     
  • How often do I need them?
     
  • What tests/results should I keep track of?
     
  • Can you explain the results of my tests?

Questions about taking the all-oral NINLARO treatment combination*

  • How should I take NINLARO in combination with lenalidomide and dexamethasone?
     
  • How will I remember to take my medication?
     
  • How should I store my medication?
     
  • What if I forget to take a dose of NINLARO?

Questions about side effects

  • What are the possible side effects of treatment?
     
  • Are there signs or symptoms I should look out for?
     
  • Should I expect any new or worsening symptoms at this point in my treatment?
     
  • What should I do if I experience any side effects? How can they be managed?

These questions are provided as a guide to prompt discussions that you may wish to have with your healthcare team, and they are not intended to be medical advice. You should follow the medical advice of your healthcare team.

Terms and Conditions apply

*NINLARO+lenalidomide+dexamethasone.

By enrolling in the Takeda Oncology Co-Pay Assistance Program (the “Program”), you acknowledge that you currently meet the eligibility criteria and will comply with the following terms and conditions:

You must be at least 18 years old, a resident of the United States or a US Territory, and have commercial (private) prescription insurance that does not cover the entire cost of the medication. The Program is not valid for patients whose prescription claims are eligible to be reimbursed, in whole or in part, by any state or federal government program, including, but not limited to, Medicare, Medicare Advantage, Medigap, Medicaid, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, Puerto Rico Government Insurance, or any state patient or pharmaceutical assistance program. Patients who become eligible for or start using government insurance will no longer be eligible for the Program. The Program is not valid if the entire cost of your prescription is reimbursable by a private insurance plan or other private health or pharmacy benefit programs. You are responsible for reporting receipt of Program assistance to any insurer, health plan, or other third party who pays for or reimburses any part of the medication cost, as may be required.

You agree that you will not submit the cost of any portion of the product dispensed pursuant to this Program to a federal or state healthcare program (including, but not limited to, Medicare, Medicare Advantage, Medicaid, TRICARE, VA, DOD, etc.), for purposes of counting it toward your out-of-pocket expenses, and to notify Takeda Oncology Here2Assist® if you become eligible for a federal or state healthcare program. This Program is not conditioned on any past, present or future purchase of any Takeda product, including refills. This Program is valid for 12 months, and your co-pay card may be renewed every 12 months, subject to continued eligibility. This offer is not valid with any other program, discount, or offer involving your prescribed Takeda Oncology medication. This offer may be rescinded, revoked, or amended without notice. No reproductions. This offer is void where prohibited by law, taxed, or restricted. Limit one offer per purchase. No income requirements or membership fees. This Program is not health insurance. Cash value of 1/100 of 1¢. For questions about this offer, please contact the Takeda Oncology Co-Pay Assistance Program, a patient support service of Takeda Oncology Here2Assist, at 1-844-817-6468, Option 2, Monday-Friday, 8AM-8PM ET.

Lab test tracker

Details on common multiple myeloma
tests and a place to record your values.

 Here2Assist patient support

Learn how we can help with coverage,
financial, and educational resource needs.